調查：只有4成半港人願意接種武漢肺炎疫苗 | 國際 | 三立新聞網 SETN COM setn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from setn.com Daily Mail and Mail on Sunday newspapers.
5 Min Read
BRUSSELS (Reuters) - The European Union failed to make a breakthrough in crisis talks with AstraZeneca on Wednesday and demanded the drugmaker spell out how it would supply the bloc with reserved doses of COVID-19 vaccine from plants in Europe and Britain.
The EU is making more comprehensive checks on vaccines before approval, which means a slower rollout of shots than former EU member Britain and growing public frustration.
The issue has been exacerbated by Anglo-Swedish AstraZeneca and Pfizer of the United States both announcing delivery hold-ups in recent weeks.
“We regret the continued lack of clarity on the delivery schedule and request a clear plan from AstraZeneca for the fast delivery of the quantity of vaccines that we reserved for Q1,” EU Health Commissioner Stella Kyriakides said in a tweet.
EU pushes for access to AstraZeneca COVID-19 vaccines from UK plants Toggle share menu
Advertisement
EU pushes for access to AstraZeneca COVID-19 vaccines from UK plants
A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken Jan 11, 2021. (Photo: REUTERS/Dado Ruvic)
27 Jan 2021 10:15PM (Updated:
28 Jan 2021 03:49AM) Share this content
Bookmark
BRUSSELS: The European Union is pushing AstraZeneca to supply the bloc with more doses of its COVID-19 vaccine from plants in Europe and Britain after the company announced delivery delays, adding to frustrations over the EU s inoculation programme.
The EU is making more comprehensive checks on vaccines before approval, which means a slower rollout of shots compared with some other regions, especially former EU member Britain.
5 Min Read
BRUSSELS (Reuters) - The European Union failed to make a breakthrough in crisis talks with AstraZeneca on Wednesday and demanded the drugmaker spell out how it would supply the bloc with reserved doses of COVID-19 vaccine from plants in Europe and Britain.
The EU is making more comprehensive checks on vaccines before approval, which means a slower rollout of shots than former EU member Britain and growing public frustration.
The issue has been exacerbated by Anglo-Swedish AstraZeneca and Pfizer of the United States both announcing delivery hold-ups in recent weeks.
“We regret the continued lack of clarity on the delivery schedule and request a clear plan from AstraZeneca for the fast delivery of the quantity of vaccines that we reserved for Q1,” EU Health Commissioner Stella Kyriakides said in a tweet.